Abstract:Hepatic inflammation is a key feature of progressive liver disease. Alterations of fatty acid (FA) metabolism and signaling may play an important role in the pathogenesis of nonalcoholic fatty liver disease (NAFLD) and its progression to nonalcoholic steatohepatitis (NASH). Moreover, FAs activate peroxisome proliferator-activated receptor α (PPARα) as a key transcriptional regulator of hepatic FA metabolism and inflammation. Since adipose triglyceride lipase (ATGL/PNPLA2) is the key enzyme for intracellular hydrolysis of stored triglycerides and determines FA signaling through PPARα, we explored the role of ATGL in hepatic inflammation in mouse models of NASH and endotoxemia. Mice lacking ATGL or hormone-sensitive lipase (HSL) were challenged with a methionine-choline-deficient (MCD) diet as a nutritional model of NASH or lipopolysaccharide (LPS) as a model of acute hepatic inflammation. We further tested whether a PPARα agonist (fenofibrate) treatment improves the hepatic phenotype in MCD- or LPS-challenged ATGL-knockout (KO) mice. MCD-fed ATGL-KO mice, although partially protected from peripheral lipolysis, showed exacerbated hepatic steatosis and inflammation. Moreover, ATGL-KO mice challenged by LPS showed enhanced hepatic inflammation, increased mortality, and torpor, findings which were attributed to impaired PPARα DNA binding activity due to reduced FABP1 protein levels, resulting in impaired nuclear FA import. Notably, liganding PPARα through fenofibrate attenuated hepatic inflammation in both MCD-fed and LPS-treated ATGL-KO mice. In contrast, mice lacking HSL had a phenotype similar to the WT mice on MCD and LPS challenge.CONCLUSION: These findings unravel a novel protective role of ATGL against hepatic inflammation which could have important implications for metabolic and inflammatory liver diseases.

Deficiency of liver adipose triglyceride lipase in mice causes progressive hepatic steatosis.

Role of adipose triglyceride lipase (PNPLA2) in protection from hepatic inflammation in mouse models of steatohepatitis and endotoxemia

PNPLA3(148M) Promotes Hepatic Steatosis by Interfering with Triglyceride Hydrolysis Through a Gain-of-Function Mechanism

Integrated Action of Autophagy and Adipose Tissue Triglyceride Lipase Ameliorates Diet-Induced Hepatic Steatosis in Liver-Specific PLIN2 Knockout Mice

Deficiency Of Liver Comparative Gene Identification-58 Causes Steatohepatitis And Fibrosis In Mice

Liver-specific Loss of Long Chain Acyl-CoA Synthetase-1 Decreases Triacylglycerol Synthesis and β-Oxidation and Alters Phospholipid Fatty Acid Composition

Adipose Tissue Deficiency of Hormone-Sensitive Lipase Causes Fatty Liver in Mice.

Discordant hepatic fatty acid oxidation and triglyceride hydrolysis leads to liver disease

Angiotensinogen in Hepatocytes Contributes to Western Diet-Induced Liver Steatosis

Mice lacking triglyceride synthesis enzymes in adipose tissue are resistant to diet-induced obesity

Fasting Energy Homeostasis in Mice with Adipose Deficiency of Desnutrin/Adipose Triglyceride Lipase

Hypertriglyceridemia in Lecithin-Cholesterol Acyltransferase-Deficient Mice is Associated with Hepatic Overproduction of Triglycerides, Increased Lipogenesis, and Improved Glucose Tolerance.

Atgl gene deletion predisposes to proximal tubule damage by impairing the fatty acid metabolism

Deficiency in Hepatic ATP-citrate Lyase Affects VLDL-triglyceride Mobilization and Liver Fatty Acid Composition in Mice.

PNPLA3, CGI‐58, and Inhibition of Hepatic Triglyceride Hydrolysis in Mice

Impaired Fasting-Induced Adaptive Lipid Droplet Biogenesis in Liver-Specific Atg5-Deficient Mouse Liver is Mediated by Persistent Nuclear Factor-Like 2 Activation

Defi Ciency of Liver Comparative Gene Identifi Cation-58 Causes Steatohepatitis and Fi Brosis in Mice

Accumulation of PNPLA3 on Lipid Droplets is the Basis of Associated Hepatic Steatosis

ATGL Mediated Adipocyte Lipolysis Exacerbates Acute Pancreatitis Severity in Mouse Models and Patients

Adipose Triglyceride Lipase in Hepatic Physiology and Pathophysiology

Hepatic ATGL mediates PPAR-α signaling and fatty acid channeling through an L-FABP independent mechanism